申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10167254B2
公开(公告)日:2019-01-01
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
本发明公开了调节或抑制吲哚胺-2,3-二氧化酶(IDO)酶活性的化合物、含有上述化合物的药物组合物以及利用本发明化合物治疗增殖性疾病(如癌症、病毒感染和/或炎症性疾病)的方法。